Free Trial

Craneware (CRW) Stock Forecast & Price Target

Craneware logo
GBX 1,546 -9.16 (-0.59%)
As of 05/8/2026 12:20 PM Eastern

Craneware - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
0
Buy
4

Based on 4 Wall Street analysts who have issued ratings for Craneware in the last 12 months, the stock has a consensus rating of "Buy." Out of the 4 analysts, 4 have given a buy rating for CRW.

Consensus Price Target

GBX 2,297.75
According to the 4 analysts' twelve-month price targets for Craneware, the average price target is GBX 2,297.75. The highest price target for CRW is GBX 2,900, while the lowest price target for CRW is GBX 570. The average price target represents a forecasted upside of 48.63% from the current price of GBX 1,546.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for CRW and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Craneware and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRW Analyst Ratings Over Time

TypeCurrent Forecast
5/9/25 to 5/9/26
1 Month Ago
4/9/25 to 4/9/26
3 Months Ago
2/8/25 to 2/8/26
1 Year Ago
5/9/24 to 5/9/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetGBX 2,297.75GBX 2,297.75GBX 2,873.67GBX 2,800
Consensus RatingBuyBuyBuyBuy

CRW Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CRW Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Craneware Stock vs. The Competition

TypeCranewareMedical Companies
Consensus Rating Score
3.00
2.30
Consensus RatingBuyHold
News Sentiment Rating
Positive News

See Recent CRW News
Neutral News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
3/25/2026
UBS Group AG logo
UBS Group
4 of 5 stars
 Reiterated RatingBuyGBX 570-57.41%
1/20/2026 Reiterated RatingBuyGBX 2,850+61.02%
1/20/2026
Berenberg Bank logo
Berenberg Bank
1 of 5 stars
 Reiterated RatingBuyGBX 2,900+63.84%
9/15/2025 Reiterated RatingBuyGBX 2,871+24.29%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:51 AM ET.


CRW Forecast - Frequently Asked Questions

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Craneware is GBX 2,297.75, with a high forecast of GBX 2,900 and a low forecast of GBX 570.

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Craneware in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CRW shares.

According to analysts, Craneware's stock has a predicted upside of 48.63% based on their 12-month stock forecasts.

Craneware has been rated by research analysts at UBS Group in the past 90 days.

Analysts like Craneware more than other "medical" companies. The consensus rating for Craneware is Buy while the average consensus rating for "medical" companies is Hold. Learn more on how CRW compares to other companies.

Brokerages With Craneware Recommendations


This page (LON:CRW) was last updated on 5/9/2026 by MarketBeat.com Staff.
From Our Partners